Late Breaking Science V: Challenges in Heart Failure Management

Nov 17, 2019 10:45am ‐ Nov 17, 2019 12:00pm

Credits: None available.

Standard: $35.00
Members: $25.00

Speaker(s):

Social Media Moderator - Drazner
10:45am - 12:00pm
Mark Drazner

Results From the Pediatric Heart Network’s Fontan Udenafil Exercise Longitudinal Trial
10:45am - 12:00pm
David Goldberg

Discussant - Sable
10:45am - 12:00pm
Craig Sable

Effect of Treatment According to Age in the Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure Trial (DAPA-HF)
10:45am - 12:00pm
Felipe Martinez

Effect of Treatment on the Kansas City Cardiomyopathy Questionnaire (KCCQ) in the Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure Trial (DAPA-HF)
10:45am - 12:00pm
John McMurray

Discussant - Lam
10:45am - 12:00pm
Carolyn Lam

LBCT: Effects of Sacubitril/Valsartan in Women Compared to Men With Heart Failure and Preserved Ejection Fraction
10:45am - 12:00pm
John McMurray

Effect of Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure
10:45am - 12:00pm
Scott Solomon

Discussant - Stevenson
10:45am - 12:00pm
Lynne Stevenson

Putting It All Together: How to Use SGLT2 Inhibitors and ARNIs in Practice
10:45am - 12:00pm
Clyde Yancy

Late Breaking Science V: Challenges in Heart Failure Management - Discussion
10:45am - 12:00pm
Panel Discussion

Credits

Credits: None available.

You must be logged in and own this session in order to post comments.